GS-0976

Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
CP Wire
Fri, 04/13/18 - 12:16 pm
Gilead Sciences
NASH
selonsertib
GS-9674
GS-0976
Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Fri, 04/13/18 - 12:10 pm
Gilead
NASH
selonsertib
GS-9674
GS-0976
In an update, Gilead spotlights top-line hits amid a mixed set of PhII data for its $600M NASH drug
Endpoints
Tue, 10/24/17 - 05:30 pm
Gilead Sciences
NASH
GS-0976